Regulación de la función de transporte de aniones orgánicos hepáticos del polipéptido tipo 1B por la proteína quinasa LYN
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Ver abstracta en PubMed
Resumen
Este resumen es generado por máquina.La pérdida de LYN quinasa altera la actividad del transportador de absorción hepática Oatp1b2, lo que puede causar interacciones medicamentosas. Este estudio revela LYN
Área De La Ciencia
- Farmacología
- La bioquímica
- Metabolismo de las drogas
Sus Antecedentes
- Las quinasas de la familia Src, incluida la LYN, modulan los transportadores involucrados en las interacciones farmacológicas.
- LYN se expresa en hepatocitos, lo que sugiere un papel en la disposición hepática de fármacos.
- La deficiencia de LYN puede alterar la fosforilación y la actividad del transportador.
Objetivo Del Estudio
- Investigar el papel de LYN en la regulación de los transportadores hepáticos de fármacos.
- Determinar si la deficiencia de LYN afecta la fosforilación y la actividad de Oatp1b2.
- Explorar las implicaciones de la regulación mediada por LYN para las interacciones entre fármacos.
Principales Métodos
- Cribado fosfo-proteómico no dirigido en hígados de ratón.
- Ensayos de absorción celular utilizando células con sobreexpresión de Oatp1b2 y hepatocitos primarios.
- Estudios farmacocinéticos en ratones tratados con el inhibidor de la LYN quinasa nilotinib o el inhibidor de Oatp1b rifampicina.
Principales Resultados
- La deficiencia de LYN redujo significativamente la fosforilación y la actividad de absorción de Oatp1b2.
- La inhibición de la LYN quinasa con nilotinib imitaba los efectos de la deficiencia de LYN.
- El nilotinib aumentó la exposición sistémica del sustrato Oatp1b2 pravastatina, similar a la rifampicina.
- El efecto de nilotinib en la exposición a pravastatina estuvo ausente en ratones con deficiencia de Oatp1b2.
Conclusiones
- LYN es un regulador clave de la absorción hepática dependiente de Oatp1b2.
- La interrupción de la actividad de la LYN quinasa representa un nuevo mecanismo para las interacciones entre fármacos.
- La actividad LYN alterada puede conducir a interacciones farmacológicas potencialmente peligrosas dependientes de Oatp1b al desactivar los procesos de transporte de eliminación.
Contact us Si estos videos no son relevantes.
Contact us Si estos videos no son relevantes.
Videos de Conceptos Relacionados
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...